Kate Haviland, CHIEF EXECUTIVE OFFICER at Blueprint Medicines Corp (BPMC), bought 1,100 shares at $43.98 ($48K) on 2022-11-03, disclosed to the SEC on 2022-11-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |